These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 25786136)
21. Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis. Garsen M; Benner M; Dijkman HB; van Kuppevelt TH; Li JP; Rabelink TJ; Vlodavsky I; Berden JH; Rops AL; Elkin M; van der Vlag J Am J Pathol; 2016 Apr; 186(4):805-15. PubMed ID: 26873445 [TBL] [Abstract][Full Text] [Related]
22. Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte. Garsen M; Sonneveld R; Rops AL; Huntink S; van Kuppevelt TH; Rabelink TJ; Hoenderop JG; Berden JH; Nijenhuis T; van der Vlag J J Pathol; 2015 Dec; 237(4):472-81. PubMed ID: 26202309 [TBL] [Abstract][Full Text] [Related]
23. Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease. Levidiotis V; Freeman C; Tikellis C; Cooper ME; Power DA Nephrology (Carlton); 2005 Apr; 10(2):167-73. PubMed ID: 15877677 [TBL] [Abstract][Full Text] [Related]
24. Heparanase regulates thrombosis in vascular injury and stent-induced flow disturbance. Baker AB; Gibson WJ; Kolachalama VB; Golomb M; Indolfi L; Spruell C; Zcharia E; Vlodavsky I; Edelman ER J Am Coll Cardiol; 2012 Apr; 59(17):1551-60. PubMed ID: 22516446 [TBL] [Abstract][Full Text] [Related]
25. Heparanase overexpression reduces carrageenan-induced mechanical and cold hypersensitivity in mice. Li L; Wang B; Gao T; Zhang X; Hao JX; Vlodavsky I; Wiesenfeld-Hallin Z; Xu XJ; Li JP Neurosci Lett; 2012 Mar; 511(1):4-7. PubMed ID: 22227299 [TBL] [Abstract][Full Text] [Related]
26. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752 [TBL] [Abstract][Full Text] [Related]
27. Overexpression of heparanase enhances T lymphocyte activities and intensifies the inflammatory response in a model of murine rheumatoid arthritis. Digre A; Singh K; Åbrink M; Reijmers RM; Sandler S; Vlodavsky I; Li JP Sci Rep; 2017 Apr; 7():46229. PubMed ID: 28401953 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of cyclooxygenase-2 predisposes to podocyte injury. Cheng H; Wang S; Jo YI; Hao CM; Zhang M; Fan X; Kennedy C; Breyer MD; Moeckel GW; Harris RC J Am Soc Nephrol; 2007 Feb; 18(2):551-9. PubMed ID: 17202413 [TBL] [Abstract][Full Text] [Related]
29. Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species. van den Hoven MJ; Waanders F; Rops AL; Kramer AB; van Goor H; Berden JH; Navis G; van der Vlag J Nephrol Dial Transplant; 2009 Sep; 24(9):2637-45. PubMed ID: 19429930 [TBL] [Abstract][Full Text] [Related]
30. Mild electrical stimulation with heat shock attenuates renal pathology in adriamycin-induced nephrotic syndrome mouse model. Teramoto K; Tsurekawa Y; Suico MA; Kaseda S; Omachi K; Yokota T; Kamura M; Piruzyan M; Kondo T; Shuto T; Araki E; Kai H Sci Rep; 2020 Oct; 10(1):18719. PubMed ID: 33128027 [TBL] [Abstract][Full Text] [Related]
31. Protective effect of sulodexide on podocyte injury in adriamycin nephropathy rats. Chen S; Fang Z; Zhu Z; Deng A; Liu J; Zhang C J Huazhong Univ Sci Technolog Med Sci; 2009 Dec; 29(6):715-9. PubMed ID: 20037813 [TBL] [Abstract][Full Text] [Related]
32. A novel role of angiopoietin-like-3 associated with podocyte injury. Liu J; Gao X; Zhai Y; Shen Q; Sun L; Feng C; Rao J; Liu H; Zha X; Guo M; Ma D; Zhang Z; Li R; Xu H Pediatr Res; 2015 Jun; 77(6):732-9. PubMed ID: 25710887 [TBL] [Abstract][Full Text] [Related]
33. α-Actinin-4 is involved in the process by which dexamethasone protects actin cytoskeleton stabilization from adriamycin-induced podocyte injury. Liu H; Gao X; Xu H; Feng C; Kuang X; Li Z; Zha X Nephrology (Carlton); 2012 Nov; 17(8):669-75. PubMed ID: 22804863 [TBL] [Abstract][Full Text] [Related]
34. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats. Fujimura T; Yamagishi S; Ueda S; Fukami K; Shibata R; Matsumoto Y; Kaida Y; Hayashida A; Koike K; Matsui T; Nakamura K; Okuda S Nephrol Dial Transplant; 2009 May; 24(5):1397-406. PubMed ID: 19042927 [TBL] [Abstract][Full Text] [Related]
36. Exposure to hydrocarbons and renal disease: an experimental animal model. Mutti A; Coccini T; Alinovi R; Toubeau G; Broeckaert F; Bergamaschi E; Mozzoni P; Nonclercq D; Bernard A; Manzo L Ren Fail; 1999; 21(3-4):369-85. PubMed ID: 10416216 [TBL] [Abstract][Full Text] [Related]
37. beta-Catenin mediates adriamycin-induced albuminuria and podocyte injury in adult mouse kidneys. Heikkilä E; Juhila J; Lassila M; Messing M; Perälä N; Lehtonen E; Lehtonen S; Sjef Verbeek J; Holthofer H Nephrol Dial Transplant; 2010 Aug; 25(8):2437-46. PubMed ID: 20237062 [TBL] [Abstract][Full Text] [Related]
38. Involvement of human heparanase in the pathogenesis of diabetic nephropathy. Katz A; Van-Dijk DJ; Aingorn H; Erman A; Davies M; Darmon D; Hurvitz H; Vlodavsky I Isr Med Assoc J; 2002 Nov; 4(11):996-1002. PubMed ID: 12489489 [TBL] [Abstract][Full Text] [Related]
39. Heparanase in Kidney Disease. van der Vlag J; Buijsers B Adv Exp Med Biol; 2020; 1221():647-667. PubMed ID: 32274730 [TBL] [Abstract][Full Text] [Related]
40. Urinary heparanase activity in patients with Type 1 and Type 2 diabetes. Rops AL; van den Hoven MJ; Veldman BA; Salemink S; Vervoort G; Elving LD; Aten J; Wetzels JF; van der Vlag J; Berden JH Nephrol Dial Transplant; 2012 Jul; 27(7):2853-61. PubMed ID: 22187315 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]